JelliSee Ophthalmics
Mclean, US · Founded 2019 · Delaware corporation
Founders & leadership
JA
Jerry ArthurNamed on SEC filing
MJ
Michael J. MalesardiNamed on SEC filing
FJ
Forrest J EllisNamed on SEC filing
AR
Amy R. JefferyNamed on SEC filing
AG
Adrienne GravesNamed on SEC filing
DA
Dimitri AzarNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.7M disclosed across 1 round · 2023
▶$3.7MraisedApr 2024 · 34 investors · BiotechnologyRule 506(b)
▶$3.7MraisedApr 2024 · 34 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jerry ArthurDirector
- Michael J. MalesardiExecutive Officer, Director
- Forrest J EllisExecutive Officer, Director
- Amy R. JefferyExecutive Officer, Director
- Adrienne GravesDirector
- Dimitri AzarDirector
- Offering amount
- $10M
- Amount sold
- $3.7M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has JelliSee Ophthalmics raised?
- JelliSee Ophthalmics has disclosed $3.7M raised across 1 round.
- Where is JelliSee Ophthalmics headquartered?
- JelliSee Ophthalmics is headquartered in Mclean, US.